Eurocine Vaccines is a pharmaceutical company. The company develops vaccines using its proprietary technology platform Endocine™, which vaccines are subsequently licensed to partners for further development and commercialization. Development is carried out in cooperation with other companies in the industry. The technology platform Endocine™ is also offered to other companies for development within certain indications. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.24
%
-6,94%
Latest
3.22
High
3.4
Low
3.15
Volume
281 964
Turnover (SEK)
924 382
Value (MSEK)
45,8

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Formue Nord A/S 6,79 6,79 2021-06-24
Avanza Pension 5,27 2,93 2021-06-30
Nordnet Pensionsförsäkring 3,31 1,84 2021-06-30
VisMederi Srl 1,73 1,73 2021-03-31
BRL Invest AB 1,59 0,89 2021-06-30
Kent Olsson 1,58 0,88 2021-06-30
Niclas Falk 1,14 0,63 2021-06-30
Göran Erlandsson 1,13 0,63 2021-06-30
Jan Kennet Karjalainen 0,87 0,48 2021-06-30
Robert Grebenstedt 0,80 0,44 2021-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream